Protease imaging of human atheromata captures molecular information of atherosclerosis, complementing anatomic imaging

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 3, 2010, Pages 449-456

  Kim, Dong Eog ^a   Kim, Jeong Yeon ^a   Schellingerhout, Dawid ^b   Kim, Eo Jin ^a   Kim, Hyang Kyoung ^c   Lee, Seulki ^d   Kim, Kwangmeyung ^d   Kwon, Ick Chan ^d   Shon, Soo Min ^a   Jeong, Sang Wuk ^a   Im, So Hyang ^a   Lee, Dong Kun ^a,e   Lee, Myoung Mook ^a   Kim, Geun Eun ^c  

^a Dongguk University Ilsan Hospital   (South Korea)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Asan Medical Center   (South Korea)

^d Korea Institute of Science and Technology   (South Korea)

^e Dongguk University   (South Korea)

Author keywords

Atherosclerosis; Cathepsin B; Molecular imaging; Protease; Structural imaging

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; CATHEPSIN B; GELATINASE A; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTEINASE;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; CAROTID ARTERY BIFURCATION; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; ECHOGRAPHY; EMBOLISM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOLECULAR IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; STENT;

AGED; CAROTID ARTERIES; CAROTID STENOSIS; CATHEPSIN B; ENDARTERECTOMY, CAROTID; FEMALE; FLUORESCENT DYES; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MOLECULAR IMAGING; PEPTIDE HYDROLASES; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; STENTS;

EID: 77649150253     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.194613     Document Type: Article

References (25)

1. Biller J, Feinberg WM, Castaldo JE, Whittemore AD, Harbaugh RE, Dempsey RJ, Caplan LR, Kresowik TF, Matchar DB, Toole JF, Easton JD, Adams HP Jr, Brass LM, Hobson RW II, Brott TG, Sternau L. Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council American Heart Association. Circulation. 1998; 97: 501-509. (Pubitemid 28090224)
2. Deguchi JO, Aikawa M, Tung CH, Aikawa E, Kim DE, Ntziachristos V, Weissleder R, Libby P. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation. 2006;114:55-62.
3. Jaffer FA, Kim DE, Quinti L, Tung CH, Aikawa E, Pande AN, Kohler RH, Shi GP, Libby P, Weissleder R. Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor. Circulation. 2007;115:2292-2298.
4. Jaffer FA, Libby P, Weissleder R. Optical and multimodality molecular imaging: insights into atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:1017-1024.
5. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
6. Papaspyridonos M, Smith A, Burnand KG, Taylor P, Padayachee S, Suckling KE, James CH, Greaves DR, Patel L. Novel candidate genes in unstable areas of human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2006;26:1837-1844.
7. Shah PK. Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol. 2003;41:15S-22S.
8. Weissleder R, Tung CH, Mahmood U, Bogdanov A Jr. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol. 1999;17:375-378.
9. Lee S, Cha EJ, Park K, Lee SY, Hong JK, Sun IC, Kim SY, Choi K, Kwon IC, Kim K, Ahn CH. A near-infrared-fluorescence-quenched goldnanoparticle imaging probe for in vivo drug screening and protease activity determination. Angew Chem Int Ed Engl. 2008;47:2804-2807.
10. Ntziachristos V, Ripoll J, Wang LV, Weissleder R. Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol. 2005;23:313-320.
11. Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat Med. 2003;9:123-128.
12. Lee DK, Nahrendorf M, Schellingerhout D, Kim DE. Will molecular optical imaging have clinically important roles in stroke management, and how? J Clin Neurol. In press.
13. Nicolaides AN, Griffin M, Kakkos SK, Geroulakos G, Kyriakou E. Evaluation of carotid plaque morphology. In: Mansour MA, Labropoulos N, eds. Vascular diagnosis. Philadelphia: Elsvier Saunders; 2005:131-148.
14. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
15. Lovett JK, Gallagher PJ, Hands LJ, Walton J, Rothwell PM. Histological correlates of carotid plaque surface morphology on lumen contrast imaging. Circulation. 2004;110:2190-2197.
16. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995; 92:1355-1374.
17. Gronholdt ML. Ultrasound and lipoproteins as predictors of lipid-rich, rupture-prone plaques in the carotid artery. Arterioscler Thromb Vasc Biol. 1999;19:2-13.
18. Polak JF, Shemanski L, O'Leary DH, Lefkowitz D, Price TR, Savage PJ, Brant WE, Reid C. Hypoechoic plaque at US of the carotid artery: an independent risk factor for incident stroke in adults aged 65 years or older. Cardiovascular Health Study. Radiology. 1998;208:649-654.
19. Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation. 2006;113:2320-2328.
20. Cheng C, Tempel D, van Haperen R, van der Baan A, Grosveld F, Daemen MJ, Krams R, de Crom R. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation. 2006;113:2744-2753.
21. Platt MO, Ankeny RF, Shi GP, Weiss D, Vega JD, Taylor WR, Jo H. Expression of cathepsin K is regulated by shear stress in cultured endo-thelial cells and is increased in endothelium in human atherosclerosis. Am J Physiol Heart Circ Physiol. 2007;292:H1479-H1486.
22. Li W, Kornmark L, Jonasson L, Forssell C, Yuan XM. Cathepsin L is significantly associated with apoptosis and plaque destabilization in human atherosclerosis. Atherosclerosis. 2009;202:92-102.
23. Loftus IM, Naylor AR, Goodall S, Crowther M, Jones L, Bell PR, Thompson MM. Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke. 2000;31:40-47.
24. Bicknell CD, Peck D, Alkhamesi NA, Cowling MG, Clark MW, Goldin R, Foale R, Jenkins MP, Wolfe JH, Darzi AW, Cheshire NJ. Relationship of matrix metalloproteinases and macrophages to embolization during endoluminal carotid interventions. J Endovasc Ther. 2004;11:483-493.
25. Kim DE, Kim JY, Schellingerhout D, Shon SM, Jeong SW, Kim EJ, Kim WK. Molecular imaging of cathepsin B proteolytic enzyme activity reflects the inflammatory component of atherosclerotic pathology and can quantitatively demonstrate the antiatherosclerotic therapeutic effects of atorvastatin and glucosamine. Mol Imaging. 2009;8:291-301.